Pharming Group Nv Stock Price on November 4, 2024
| PHAR Stock | USD 9.32 0.05 0.54% |
If you're considering investing in Pharming Stock, it is important to understand the factors that can impact its price. As of today, the current price of Pharming Group stands at 9.32, as last reported on the 12th of December 2024, with the highest price reaching 9.39 and the lowest price hitting 9.05 during the day. Pharming Group appears to be not too volatile, given 3 months investment horizon. Pharming Group NV maintains Sharpe Ratio (i.e., Efficiency) of 0.12, which implies the firm had a 0.12% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Pharming Group NV, which you can use to evaluate the volatility of the company. Please evaluate Pharming Group's Semi Deviation of 2.93, coefficient of variation of 707.02, and Risk Adjusted Performance of 0.11 to confirm if our risk estimates are consistent with your expectations.
At this time, Pharming Group's Total Stockholder Equity is relatively stable compared to the past year. As of 12/12/2024, Common Stock Shares Outstanding is likely to grow to about 689.9 M, while Common Stock is likely to drop slightly above 6.6 M. . As of 12/12/2024, Price Earnings To Growth Ratio is likely to grow to 0.53, while Price To Sales Ratio is likely to drop 3.62. Pharming Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Pharming |
Sharpe Ratio = 0.1186
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PHAR | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.32 actual daily | 29 71% of assets are more volatile |
Expected Return
| 0.39 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Pharming Group is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pharming Group by adding it to a well-diversified portfolio.
Price Book 2.785 | Enterprise Value Ebitda 72.7487 | Price Sales 2.2007 | Shares Float 500.4 M | Wall Street Target Price 27 |
Related Headline
Mineralys Therapeutics, Headline on 4th of November 2024
Mineralys Therapeutics to Announce Third Quarter 2024 Financ... by finance.yahoo.com
RADNOR, Pa., Nov. 04, 2024 -- Mineralys Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease and other diseases driven by dysregulated aldosterone, today announced it will report its financial results from the third quarter ended September 30, 2024, after the financial markets close on Monday, November 11, 2024. Monday, November 11th 430 p.m. ET Domestic1-877-407-912
Pharming Group Valuation on November 4, 2024
It is possible to determine the worth of Pharming Group on a given historical date. On November 4, 2024 Pharming was worth 8.41 at the beginning of the trading date compared to the closed value of 8.33. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Pharming Group stock. Still, in general, we apply an absolute valuation method to find Pharming Group's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pharming Group where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Pharming Group's related companies.
| Open | High | Low | Close | Volume | |
| 8.50 | 8.90 | 8.46 | 8.52 | 7,831 | |
11/04/2024 | 8.41 | 8.69 | 8.28 | 8.33 | 10,576 |
| 8.20 | 8.20 | 8.13 | 8.13 | 1,021 |
| Backtest Pharming Group | | | Pharming Group History | | | Pharming Group Valuation | Previous | Next |
Pharming Group Trading Date Momentum on November 4, 2024
| On November 05 2024 Pharming Group NV was traded for 8.13 at the closing time. The top price for the day was 8.20 and the lowest listed price was 8.13 . The trading volume for the day was 1 K. The trading history from November 5, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.40% . The trading delta at closing time against the current closing price is 3.84% . |
Pharming Group NV Fundamentals Correlations and Trends
By evaluating Pharming Group's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Pharming Group's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Pharming financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Pharming Group Stock history
Pharming Group investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pharming is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pharming Group NV will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pharming Group stock prices may prove useful in developing a viable investing in Pharming Group
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 657 M | 689.9 M | |
| Net Income Applicable To Common Shares | 15.7 M | 8.3 M |
Pharming Group Quarterly Net Working Capital |
|
Pharming Group Stock Technical Analysis
Pharming Group technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Pharming Group Period Price Range
Low | December 12, 2024
| High |
0.00 | 0.00 |
Pharming Group NV cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Pharming Group December 12, 2024 Market Strength
Market strength indicators help investors to evaluate how Pharming Group stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pharming Group shares will generate the highest return on investment. By undertsting and applying Pharming Group stock market strength indicators, traders can identify Pharming Group NV entry and exit signals to maximize returns
Pharming Group Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Pharming Group's price direction in advance. Along with the technical and fundamental analysis of Pharming Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pharming to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.11 | |||
| Jensen Alpha | 0.5693 | |||
| Total Risk Alpha | (0.07) | |||
| Sortino Ratio | 0.1044 | |||
| Treynor Ratio | (0.50) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Pharming Stock Analysis
When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.